Organogenesis Holdings Inc.ORGONASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +27.10% | -21.17% | -22.62% | +30.98% | +78.13% |
| Gross Profit Growth | +33.00% | -22.53% | -27.60% | +29.68% | +84.16% |
| EBITDA Growth | +33.10% | -11136.81% | +0.00% | +154.81% | +393.42% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +232.06% | +538.31% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +74.90% | +469.53% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +18.28% | +518.10% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +19.44% | +516.44% |
| Weighted Average Shares Growth | +0.58% | -4.22% | -4.31% | -4.29% | -3.61% |
| Weighted Average Shares Diluted Growth | +0.23% | -4.22% | -4.31% | -2.30% | +0.03% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +3.05% | +0.00% | -793.82% | -64.59% | +260.43% |
| Free Cash Flow Growth | +3.94% | +0.00% | -1377.50% | -86.22% | +358.92% |
| Receivables Growth | +33.98% | +7.46% | +13.63% | +66.66% | +97.93% |
| Inventory Growth | -7.20% | +5.94% | +22.91% | +46.41% | +13.00% |
| Asset Growth | +8.23% | +1.94% | +4.05% | +14.24% | +20.25% |
| Book Value per Share Growth | +37.48% | +38.22% | +43.27% | +44.79% | +16.84% |
| Debt Growth | -63.71% | -64.07% | -63.84% | -62.10% | +206.71% |
| R&D Expense Growth | -2.04% | -16.94% | -33.31% | +27.81% | -10.79% |
| SG&A Expenses Growth | +20.32% | +0.26% | -3.57% | +10.35% | +35.63% |